Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients

Cytokine

Volumn 55, Issue 1, 2011, Pages 29-33

  Fragoso, José Manuel ^a,b   Vallejo, Maite ^a   Alvarez León, Edith ^a   Delgadillo, Hilda ^a   Peña Duque, Marco Antonio ^a   Cardoso Saldaña, Guillermo ^a   Posadas Romero, Carlos ^a   Martínez Ríos, Marco Antonio ^a   Vargas Alarcón, Gilberto ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Acute coronary syndrome; Genetic susceptibility; Inflammation; Interleukin 10; Polymorphisms

Indexed keywords

PHOSPHODIESTERASE I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE MAP; HUMAN; INTERLEUKIN 10 GENE; MAJOR CLINICAL STUDY; MALE; MEXICAN; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE CORONARY SYNDROME; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79956341665     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.03.021     Document Type: Article

References (35)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Garcia-Moll X. Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting?. Rev Esp Cardiol 2005, 58:615-617.
3. Luis A.J. Atherosclerosis. Nature 2000, 407:233-241.
4. Libby P. Inflammation and atherosclerosis. Nature 2002, 420:868-874.
5. Virmani R., Kolodgie F.D., Burke A.P., Finn A.V., Gold H.K., Tulenko T.N., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Thromb Vasc Biol 2005, 25:2054-2061.
6. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003, 107:2109-2114.
7. Achar S.A., Kundu S., Narcroos W.A. Diagnosis of acute coronary syndromes. Am Fam Physician 2005, 72:119-126.
8. Mouco O.M., Nicolau J.C., Souza T de R., Maia L.N., Ramirez J.A. Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event-temporal trends. Arq Bras Cardiol 2005, 87:28-36.
9. Malarstig A., Eriksson P., Hamsten A., Lindahl B., Wallentin L., Siegbahn A. Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart 2006, 94:724-729.
10. Carter A.M. Inflammation thrombosis and acute coronary syndromes. Diab Vasc Dis Res 2005, 2:113-123.
11. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-2153.
12. Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001, 103:947-953.
13. Vohnout B., Di Castelnuovo A., Trotta R., D'Orazi A., Panniteri G., Montali A., et al. Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 2003, 88:54-60.
14. Valgimigli M., Ceconi C., Malagutti P., Merli E., Soukhomovskaia O., Francolini G., et al. Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction. Circulation 2005, 111:863-870.
15. Olson T.S., Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283:R7-R28.
16. Waehre T., Halvorsen B., Damås J.K., Yndestad A., Brosstad F., Gullestad L., et al. Inflammatory imbalance between IL-10 and TNF-alpha in unstable angina potential plaque stabling effects of IL-10. Eur J Clin Invest 2002, 32:803-810.
17. Girndt M., Köhler H. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrol Dial Transplnat 2003, 18:1976-1979.
18. Lio D., Candore G., Crivello A., Scola L., Colonna-Romano G., Cavallone L., et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004, 41:790-794.
19. Koch W., Kastrati A., Bittiger C., Mehilli J., von Beckerath N., Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001, 159:137-144.
20. Smith D.A., Irving S.D., Sheldon J., Cole D., Kaski J.C. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001, 104:46-749.
21. Fichtlscherer S., Breuer S., Heeschen C., Dimmeler S., Zeiher A.M. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 2004, 44:44-49.
22. Mallat Z., Heymes C., Ohan J., Faggin E., Leseche G., Tedgui A. Expression of interleukin-10 in advance human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Throm Vasc Biol 1999, 19:611-616.
23. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999, 85:E17-E24.
24. Kim J.M., Brannan C.I., Copeland N.G., Jenkins N.A., Khan T.A., Moore K.W. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992, 148:3618-3623.
25. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46:120-128.
26. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999, 42:1101-1108.
27. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task force on the Definition and Classification of Cardiomyopathies. Circulation 1996, 93:841-842.
28. Lahiri D.K., Numberger J.I. A rapid non-enzymatic method for the preparation HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991, 19:5444.
29. Chin H.J., Na K.Y., Kim S.J., Oh K.H., Kim Y.S., Lim C.S., et al. Interleukin-10 promoter polymorphisms are associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea. J Korean Med Sci 2005, 20:989-993.
30. Flores J., DuPont H.L., Lee S.A., Belkind-Gerson J., Paredes M., Mohamed J.A., et al. Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol 2008, 15:1194-1198.
31. Zhang X., Hei P., Deng L., Lin J. Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 2007, 13:135-140.
32. Sugimoto M., Furuta T., Shirai N., Nakamura A., Kajimura M., Sugimura H., et al. Effects of interleukin-10 gene polymorphisms on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 2007, 22:1443-1449.
33. Wattanattum A., Monocha S., Groshaus H., Russell J.A., Walley K.R. Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest 2005, 128:1690-1698.
34. Ko K.P., Park S.K., Cho L.Y., Gwack J., Yang J.J., Shin A., et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr 2009, 139:1008-1012.
35. Temple S.E., Lim E., Cheong K.Y., Almeida C.A., Price P., Ardlie K.G., et al. Alleles carried at position -819 and -592 of the IL-10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003, 55:629-632.